Organization: Health Canada
Year: 2020
Month: October
Request Number: A-2020-000961
Request Summary: The most current Risk Management Plan (RMP) and RMP review report for Novolin (Insulin) associated with any of the following Drug Identification Numbers (DIN): 02024217, 02025248, 02024314, 02024322, 02024225, 02024233, 02024268, 02024284 by Novo Nordisk Canada Inc.
Disposition: No records exist
Number of pages: 0